Etripamil: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Etripamil. Educational only — not medical advice.
Labeled uses
CARDAMYST is indicated for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults.
Source: FDA labeling via NIH DailyMed (set a92170b9…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.